MedTrace Logo

Environmental Influence on Mental Illness Via Modifications of Genomes and Metabolomes in Adolescents With Autism

NCT06299618 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-08-14

No results posted yet for this study

Summary

The aim of the study is to enrich the understanding of the physiological mechanisms that predispose autistic adolescents to mental illness. It will inform a possible pathway and biomarker handprint of mental illness severity and prognosis to formulate a neurobiologically informed personalization strategy that could be applied for selecting appropriate Evidence Based Intervention (EBI) for treating an adolescent formally diagnosed with Autism.

Conditions

Sponsors & Collaborators

  • University of Southampton

    collaborator OTHER

  • Carol Davila University of Medicine and Pharmacy

    collaborator OTHER

  • Microlink PC UK LTE

    collaborator UNKNOWN

  • Engineering Ingegneria Informatica SpA

    collaborator UNKNOWN

  • MEDEA SRL

    collaborator UNKNOWN

  • ORTHOKEY ITALIA SRL

    collaborator UNKNOWN

  • University College Cork

    lead OTHER

Principal Investigators

  • Deirdre Murray, PhD · University College Cork, Cork, Ireland

  • Geraldine Boylan, PhD · University College Cork, Cork, Ireland

  • Mihai Berteanu, PhD · University of Medicine and Pharmacy, Bucharest, Romania

  • Samuele Cortese, PhD · University of Southampton, Southampton, UK

  • Koushik Maharatna, PhD · University of Southampton, Southampton, UK

Eligibility

Min Age
11 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2025-05-31
Completion
2025-12-31

Countries

  • Ireland
  • Romania
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06299618 on ClinicalTrials.gov